General | 04 November 2026
Evonik’s third-quarter profit jumps 40%
Specialty chemicals giant expects full-year earnings to land in the upper half of its guidance range
Specialty chemicals giant expects full-year earnings to land in the upper half of its guidance range
Despite the margin pressure, Clariant maintained its full-year 2026 guidance, backed by a strong order book, particularly in Catalysts
In Q3, the company delivered operating cash flow of $538 million and free cash flow of $461 million.
Advantaged investments, technology, and $16.9 billion in structural cost savings since 2019 are expanding our earnings power
The global agricultural leader registered group sales of $17.3 billion for the first nine months of the year
The numbers underline the company's ability to sustain profitable growth despite challenging global headwinds
Neogen, however, continued to face cost pressures arising from the Dahej plant rebuild, tolling arrangements, capital expenditure at NIL and elevated input costs
The most notable highlight of the quarter was the PAT which skyrocketed by an extraordinary 1,259%
The company's operating revenue, however, surged 40.9% year-on-year to Rs 2,773 crore in Q2 FY27
Revenue from operations, however, surged 116.51% year-on-year to Rs 272.88 crore
The company reported a consolidated revenue of Rs 346.7 crore in Q2 FY27
The next product planned for commercialization is N-Methyl Morpholine
Board approves Rs. 70 crore CapEx plan
Consolidated revenue from operations jump 104.9% year-on-year to Rs.934.37 crore
Revenue from operations grew by 13.3% YoY to reach Rs. 826 crore
Net income for the quarter stood at $30 million
H1 FY27 PAT witnessed a massive 155.7% YoY explosion, hitting Rs. 113.77 crore as against Rs. 44.45 crore
However, statutory Profit After Tax (PATMI) fell 24% YoY to Rs. 421 crore due to an 18% spike in net finance costs
Color business leads growth as operating income surges 25.5%; company raises its full-year earnings outlook
Adjusted EBITDA also declined to $191.4 million from $222.4 million in the third quarter of 2025
Subscribe to our newsletter & stay updated.
